Mankind Pharma Limited — Important, 11-05-2025: General Updates

Mankind Pharma faces an additional tax demand of INR 91.01 Cr for AY 2023-24 due to disallowed expenses and adjustments under tax provisions. The company contests the demand, expects no significant financial or operational impact, and plans to appeal while seeking relief through prepaid taxes from merged entities.